Yext (NYSE:YEXT – Get Free Report) and Firefly Neuroscience (NASDAQ:AIFF – Get Free Report) are both small-cap business services companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, profitability, dividends, earnings and analyst recommendations.
Insider & Institutional Ownership
71.0% of Yext shares are held by institutional investors. Comparatively, 5.0% of Firefly Neuroscience shares are held by institutional investors. 5.2% of Yext shares are held by insiders. Comparatively, 6.4% of Firefly Neuroscience shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Yext and Firefly Neuroscience’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Yext | 8.48% | 29.61% | 7.59% |
| Firefly Neuroscience | -1,740.98% | -229.99% | -158.47% |
Earnings and Valuation
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Yext | $446.58 million | 1.06 | $37.87 million | $0.06 | 64.25 |
| Firefly Neuroscience | $1.14 million | 23.74 | -$19.88 million | ($1.80) | -1.02 |
Yext has higher revenue and earnings than Firefly Neuroscience. Firefly Neuroscience is trading at a lower price-to-earnings ratio than Yext, indicating that it is currently the more affordable of the two stocks.
Analyst Ratings
This is a summary of recent recommendations and price targets for Yext and Firefly Neuroscience, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Yext | 1 | 3 | 2 | 0 | 2.17 |
| Firefly Neuroscience | 1 | 0 | 0 | 0 | 1.00 |
Yext currently has a consensus price target of $7.50, suggesting a potential upside of 94.55%. Given Yext’s stronger consensus rating and higher possible upside, equities analysts plainly believe Yext is more favorable than Firefly Neuroscience.
Risk & Volatility
Yext has a beta of 1.19, indicating that its stock price is 19% more volatile than the S&P 500. Comparatively, Firefly Neuroscience has a beta of 0.58, indicating that its stock price is 42% less volatile than the S&P 500.
Summary
Yext beats Firefly Neuroscience on 12 of the 14 factors compared between the two stocks.
About Yext
Yext, Inc. organizes business facts to provide answers to consumer questions in North America and internationally. It operates Yext platform, a cloud-based platform that allows its customers to offer answers to consumer questions, to control the facts about their businesses and the content of their landing pages, and to manage their consumer reviews; and provides customers to update their information and content through its publisher network of maps, apps, search engines, intelligent GPS systems, digital assistants, vertical directories, and social networks, as well as professional services. The company’s platform also enables its customers to centralize, control and manage data fields, including store information comprising name, address, phone number, and holiday hours; professional information, such as headshot, specialties, and education; job information consists of title and description; FAQs and other information. It serves various industries, such as healthcare, hospitality, food services, retail, and financial services. Yext, Inc. was incorporated in 2006 and is headquartered in New York, New York.
About Firefly Neuroscience
Firefly Neuroscience, Inc., a medical technology and artificial intelligence company, provides neuroscientific solutions that improve outcomes for patients with mental illnesses and neurological disorders. The company offers Brain Network Analytics, a software that focuses on diagnostic and treatment for people suffering from mental illnesses and cognitive disorders, including depression, dementia, anxiety disorders, concussions, and attention-deficit/hyperactivity disorder. It serves pharmaceutical companies and medical practitioners. Firefly Neuroscience, Inc. is based in Toronto, Canada.
Receive News & Ratings for Yext Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Yext and related companies with MarketBeat.com's FREE daily email newsletter.
